Mercer Global Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
+7,271
| New | +$201K | ﹤0.01% | 2046 |
|
|
2024
Q4 | – | Sell |
-9,609
| Closed | -$245K | – | 2202 |
|
|
2024
Q3 | $245K | Sell |
9,609
-6,981
| -42% | -$178K | ﹤0.01% | 1699 |
|
|
2024
Q2 | $310K | Sell |
16,590
-1,099
| -6% | -$20.5K | ﹤0.01% | 1557 |
|
|
2024
Q1 | $349K | Sell |
17,689
-1,095
| -6% | -$21.6K | ﹤0.01% | 1480 |
|
|
2023
Q4 | $329K | Buy |
18,784
+1,626
| +9% | +$28.5K | ﹤0.01% | 1551 |
|
|
2023
Q3 | $298K | Sell |
17,158
-6,066
| -26% | -$105K | ﹤0.01% | 1539 |
|
|
2023
Q2 | $327K | Buy |
23,224
+5,058
| +28% | +$71.2K | ﹤0.01% | 1464 |
|
|
2023
Q1 | $195K | Buy |
+18,166
| New | +$195K | ﹤0.01% | 1741 |
|